These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21041328)

  • 21. Early treatment: PreCISe-ly what the patient needs.
    Montalban X
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S2-6. PubMed ID: 20106344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The challenge for preventive cardiology.
    Kotseva K; Wood D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S19-23. PubMed ID: 19675431
    [No Abstract]   [Full Text] [Related]  

  • 23. [To know own diagnosis or not--that is the question].
    Quensel M
    Lakartidningen; 2001 Apr; 98(14):1695. PubMed ID: 11379173
    [No Abstract]   [Full Text] [Related]  

  • 24. Meeting the challenge of multiple sclerosis. Part I. Treating the person and the disease.
    Halper J; Holland N
    Am J Nurs; 1998 Oct; 98(10):26-31; quiz 32. PubMed ID: 9803215
    [No Abstract]   [Full Text] [Related]  

  • 25. [Patient information in multiple sclerosis].
    Wöllner U
    Dtsch Med Wochenschr; 1986 Mar; 111(12):478. PubMed ID: 3948716
    [No Abstract]   [Full Text] [Related]  

  • 26. [Update: treatment of multiple sclerosis].
    Kümpfel T; Hohlfeld R
    MMW Fortschr Med; 2009 Mar; 151(13):70-2. PubMed ID: 19504824
    [No Abstract]   [Full Text] [Related]  

  • 27. [Corticosteroids in the treatment of multiple sclerosis and optic neuritis].
    Elovaara I; Pirttilä T
    Duodecim; 2000; 116(15):1547-54. PubMed ID: 12001474
    [No Abstract]   [Full Text] [Related]  

  • 28. The management of multiple sclerosis in children: a European view.
    Ghezzi A; Banwell B; Boyko A; Amato MP; Anlar B; Blinkenberg M; Boon M; Filippi M; Jozwiak S; Ketelslegers I; Kornek B; Lim M; Lindstrom E; Nadj C; Neuteboom R; Rocca MA; Rostasy K; Tardieu M; Wassmer E; Catsman-Berrevoets C; Hintzen R
    Mult Scler; 2010 Oct; 16(10):1258-67. PubMed ID: 20685764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article].
    IFNB Multiple Sclerosis Study Group
    Neurology; 2001 Dec; 57(12 Suppl 5):S3-9. PubMed ID: 11902592
    [No Abstract]   [Full Text] [Related]  

  • 30. The uninvited guest. An overview of multiple sclerosis.
    Andes RJ
    Adv Nurse Pract; 2008 Jan; 16(1):37-40; quiz 41. PubMed ID: 20014741
    [No Abstract]   [Full Text] [Related]  

  • 31. [Copolymer 1 in therapy of multiple sclerosis].
    Weilbach FX; Voltz R; Hohlfeld R; Hartung HP
    Nervenarzt; 1995 Jun; 66(6):473-7. PubMed ID: 7543660
    [No Abstract]   [Full Text] [Related]  

  • 32. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
    Frohman EM; Havrdova E; Lublin F; Barkhof F; Achiron A; Sharief MK; Stuve O; Racke MK; Steinman L; Weiner H; Olek M; Zivadinov R; Corboy J; Raine C; Cutter G; Richert J; Filippi M
    Arch Neurol; 2006 Apr; 63(4):614-9. PubMed ID: 16606781
    [No Abstract]   [Full Text] [Related]  

  • 33. [EDMUS--a new European databank for multiple sclerosis. A brief introduction of ongoing and planned multicenter studies within the scope of the "European Concentrated Action for Multiple Sclerosis"].
    Flachenecker P; Hartung HP
    Nervenarzt; 1996 Apr; 67(4):277-82. PubMed ID: 8684505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment with beta-interferon should be started already after the first attack of MS].
    Söderström M
    Lakartidningen; 2001 Feb; 98(6):587-90, 593-4. PubMed ID: 11475246
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L
    Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
    [No Abstract]   [Full Text] [Related]  

  • 36. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.
    De Stefano N; Filippi M; Miller D; Pouwels PJ; Rovira A; Gass A; Enzinger C; Matthews PM; Arnold DL
    Neurology; 2007 Nov; 69(20):1942-52. PubMed ID: 17998486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS.
    Lublin FD; Reingold SC
    Ann Neurol; 2001 May; 49(5):677-81. PubMed ID: 11357961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health education of multiple sclerosis patients and their families.
    Adamczyk K
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():129-32. PubMed ID: 11205752
    [No Abstract]   [Full Text] [Related]  

  • 39. The patient with multiple sclerosis.
    Samonds RJ; Cammermeyer M
    Nursing; 1985 Sep; 15(9):60-4. PubMed ID: 3848747
    [No Abstract]   [Full Text] [Related]  

  • 40. [Rehabilitation in multiple sclerosis].
    Kesselring J; Mertin J
    Schweiz Rundsch Med Prax; 1991 Oct; 80(41):1120-3. PubMed ID: 1947541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.